## **Core Concept**
Kawasaki disease is an acute febrile illness of childhood characterized by inflammation in the walls of medium-sized arteries, particularly the **coronary arteries**. It leads to potential complications such as coronary artery aneurysms. The primary goal of treatment is to reduce inflammation, prevent coronary artery complications, and manage symptoms.

## **Why the Correct Answer is Right**
The treatment of choice for Kawasaki disease is **intravenous immunoglobulin (IVIG)**, often administered in combination with **aspirin**. IVIG works by reducing the duration of fever and the incidence of coronary artery abnormalities, likely through anti-inflammatory and immunomodulatory effects. Early treatment with IVIG within the first 10 days of illness significantly improves outcomes.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while **aspirin** is used in the treatment of Kawasaki disease, it is not the sole treatment of choice. Aspirin helps with fever reduction and has antiplatelet effects but does not prevent coronary artery aneurysms on its own.
- **Option B:** This option might suggest another treatment, but without specifics, it's hard to address directly. However, treatments like **steroids** are sometimes used but not as a first-line treatment due to potential to increase the risk of coronary artery aneurysms when used alone.
- **Option C:** Similarly, this option lacks specificity but could imply other treatments like **plasma exchange** or experimental therapies, which are not standard first-line treatments.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that **early diagnosis and treatment of Kawasaki disease with IVIG within the first 10 days of illness** significantly reduce the risk of coronary artery complications. A classic clinical clue is the presence of **fever for more than 5 days along with at least four of the five classic criteria**: bilateral nonexudative conjunctivitis, cervical lymphadenopathy, polymorphous exanthem, changes in extremities (erythema of palms and soles, edema), and oral mucosal changes.

## **Correct Answer:** D. IVIG.